As TransEnterix CEO, Todd Pope, gets ready to present at the J.P. Morgan Healthcare Conference later this afternoon, the company provided a corporate update highlighting their capital sales and revenue for the fourth quarter....
Medtronic plc ($MDT) and its strategic technology partner, IBM ($IBM) Watson Health, announced a new feature for the Sugar.IQ personal diabetes assistant app called IQcast. Using artificial intelligence (AI) technology from IBM Watson Health, the feature aims to predict the likelihood of an individual experiencing a low glucose event within an upcoming 1-4 hour window....
2018 was an exciting year for Medtechy and we would like to thank you all for visiting, reading and sharing. Over the course of 2018, we launched a number of new features to our site, including a new home page with up-to-date news and insight for the medical technology industry....
Edwards Lifesciences ($EW) today announced that the SAPIEN 3 Ultra system has received FDA approval for transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients who are determined to be at intermediate or greater risk of open-heart surgery...
InspireMD ($NSPR) recently announced the publication of a meta-analysis of four clinical studies involving dual layered and mesh-covered stents in the December 10, 2018 issue of JACC: Cardiovascular Interventions....
Hologic (Nasdaq: HOLX) Cynosure division recently announced the North American launch of the FDA-cleared TempSure Surgical RF technology...
Smith & Nephew today announced that it has agreed to acquire Ceterix Orthopaedics, the developer of the NovoStitch Pro Meniscal Repair System for an initial cash consideration of $50 million and up to a further $55 million over the next five years, contingent on financial performance....
In October of 2017, TransEnterix received 510(k) clearance for their Senhance robotic surgery system, becoming the first new entrant in the field of abdominal surgical robotics in nearly 20 years....
Intersect ENT ($XENT) today announced the enrollment of the first patient in the company’s study of its newest platform product, the ASCEND investigational drug-coated sinus balloon. ...
Titan Medical today announced seven new patent grants and notices of allowance related to its single-port robotic surgery technology, including patents covering multi-articulating instruments, robotic system control and user interfaces. Including these new patents and notices,...